NCT01655316已完成4 期
Oral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence Control
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 90
- 主要终点
- Recurrence Control
研究概览
简要总结
PSVT is a common rhythm disorder in emergency department which can be recurrent in some cases.
Intravenous Adenosine is the drug of choice in PSVT control in acute settings but is a very short acting agent.
Providing a complementary medication to decrease the rate of recurrence of PSVT after its initial control will be promising.
This study evaluates the role of the oral Verapamil in recurrence control of PSVT in emergency situations.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age>18 years old
- •PSVT on emergency department presentation
排除标准
- •Instability in hemodynamic status
- •Allergy to Verapamil
研究组 & 干预措施
Verapamil
Experimental
40 mg Verapamil Per Oral
干预措施: Verapamil (Drug)
结局指标
主要结局
Recurrence Control
时间窗: 2 hours
次要结局
未报告次要终点
研究者
相似试验
招募中
3 期
Efficacy of Adenosine as Compared to Verapamil in Paroxysmal Supraventricular Tachycardia (pSVT) PatientsSupraventricular Tachycardia (SVtach)NCT06717685Rashid Latif Medical College210
进行中（未招募）
4 期
Atrioventricular Block and Cluster Headache (SEVA)Cluster HeadacheNCT04406259Centre Hospitalier Universitaire de Nice60
已完成
不适用
Safety and Efficacy of Paramedic Treatment of Regular Supraventricular TachycardiaSupraventricular TachycardiaNCT02216240Barts & The London NHS Trust86
已完成
不适用
A Real-world Study of Cardiac Ablation for PSVT Using ST CatheterAVRT, AVNRTNCT04923815Johnson & Johnson Medical (Shanghai) Ltd.300
终止
不适用
The PSVT Place Registry.Paroxysmal Supraventricular Tachycardia (PSVT) Registry.Paroxysmal Supraventricular Tachycardia (PSVT)NCT03353610Milestone Pharmaceuticals Inc.354